Clinical Trials Directory

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis--The ATTRACT Trial

The purpose of this study is to determine if the use of adjunctive Pharmacomechanical Catheter Directed Thrombolysis, which includes the intrathrombus administration of rt-PA--Activase (Alteplase),can prevent the post-thrombotic syndrome(PTS)in patients with symptomatic proximal deep vein thrombosis(DVT)as compared with optimal standard DVT therapy alone.

Stanford is now accepting new patients for this trial.

Investigator(s):

Intervention(s):

  • drug : Recombinant tissue plasminogen activator (rt-PA)

Phase: Phase 3

Eligibility

Ages Eligible For Study:

16 Years - 75 Years

Inclusion Criteria

- Symptomatic proximal DVT involving the iliac, common femoral, and/or femoral vein.

External Links

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Kamil Unver
6507259810
Recruiting

Footer Links: